Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Receives $18.33 Average PT from Brokerages
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been given a consensus rating of “Buy” by the seven research firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the […]
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Get Free Report) has been given a consensus rating of “Buy” by the seven research firms that are currently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has issued a strong buy recommendation on the […]
